Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ITPRIP antisense RNA 1 (ITPRIP-AS1) is a long non-coding RNA (lncRNA) transcribed from chromosome 10q25.1 (genomic position: chr10:104,323,368-104,327,004, plus strand)[1][7]. It is classified as an antisense lncRNA, meaning it is transcribed from the DNA strand opposite to a protein-coding or other gene; these RNAs can regulate gene expression through mechanisms such as RNA-RNA interactions and epigenetic modifications[3][7]. ITPRIP-AS1 has two known exons and a transcript size of approximately 1,275 base pairs[7]. There is currently no strong evidence that ITPRIP-AS1 produces a protein or has direct involvement in disease, nor is it a therapeutic target; rather, it may act through regulation of gene expression at the RNA level, consistent with general properties of antisense lncRNAs[3][7]. Aliases identified for ITPRIP-AS1 include "lnc-ITPRIP-6:1" and "ucscGeneNc_uc001kyj_2"[7]. No documented interacting drugs, established biomarker roles, or specific safety concerns have been reported for this molecule. There is also no indication that the entry is misnamed or represents an error.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ITPRIP antisense RNA 1 (ITPRIP-AS1).